Summary
Faraday Pharmaceuticals, Inc.
Founded in 2014
Description
Faraday Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing drugs to prevent and treat cardiac and skeletal muscle loss. Their lead program, FDY 5301, is being developed to address the unmet need in cardiovascular medici...
Strengths
- Revenue generated per employee is greater than industry average
- Since Faraday Pharmaceuticals, Inc. was founded, the company has grown faster than the industry average
Weaknesses
- Faraday Pharmaceuticals, Inc. has a very small market share in their industry
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Variance of revenue growth is more than the industry average
Annual Revenue
Faraday Pharmaceuticals, Inc.'s annual revenue
$3532000
Based on Kona Equity data
-
Revenue per employee
$271692
-
Variance of revenue growth
4.38
-
Annual revenue growth since founding
$441500
-
Revenue growth rate from first known quarter to current
-41.1%
Employee Count
13 employees
-
Employee growth rate from first known quarter to current
-43.3%
Executives
Mary Schornak
Controller
m**@faradaypharma.comBen Haber
Senior Director, Data Management
b**@faradaypharma.comLori Siegel
Manager, Product Assessment
l**@faradaypharma.comPatrick Rock
General Counsel
p**@faradaypharma.comMichael Insko
Director, Preclinical Sciences
m**@faradaypharma.comRonald Kierpa
Chief Corporate Development Officer
r**@faradaypharma.comBrian Blackman
Chief Financial & Business Officer
b**@faradaypharma.comShannon Wilson
Vice President, Clinical Operations
s**@faradaypharma.comTara Allen
Associate Director, Clinical Operations
t**@faradaypharma.comJack Galvan
Clinical Research Associate II
j**@faradaypharma.comStephen Hill
CEO
s**@faradaypharma.comRandall Tressa
Vice President, Regulatory Affairs
r**@faradaypharma.comPhone Pharmaceuticals
Chief Executive Officer
p**@faradaypharma.comSerafima Golembo
Manager, Operations
s**@faradaypharma.comAmber Cole
AP Specialist
a**@faradaypharma.comChristian Buhagiar
Manager, Clinical Trial
c**@faradaypharma.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Arog Pharmaceuticals
arogpharma.com- Founded in 2010
- Location: Plano, TX
- Annual Revenue: $3.2M
- Employees: 15
- AROG Pharmaceuticals is a privately held, late stage biopharmaceutical company based in Dallas, Texas. We are focused on developing treatments for people with rare cancers. Our mission is to bring cures for cancers with a high unmet need. We collaborat...
SystImmune Inc.
systimmune.com- Founded in 2014
- Location: Redmond, WA
- Annual Revenue: $7.2M
- Employees: 32
- SystImmune, Inc. is a biopharmaceutical company focused on developing novel therapeutic bi-specific and multi-specific antibodies, as well as antibody drug conjugates (ADCs) for the treatment of cancer. Our objective is to create biologics that work th...
Bexion Pharmaceuticals
bexionpharma.com- Founded in 2006
- Location: Covington, KY
- Annual Revenue: $3.4M
- Employees: 16
- Bexion Pharmaceuticals is a small biotech company located in Covington, Kentucky devoted to developing innovative cures for cancer. The companys lead compound, BXQ 350, is a novel S1P modulator. With our highly experienced biotech leadership team and ...
ICA Therapeutics
reperlin.com- Founded in 2015
- Location: Houston, TX
- Annual Revenue: $1.3M
- Employees: 8
Synvista Therapeutics
synvista.com- Location: Montvale, NJ
- Annual Revenue: $2.4M
- Employees: 11
- Learn about working at SYNVISTA THERAPEUTICS INC. Join LinkedIn today for free. See who you know at SYNVISTA THERAPEUTICS INC, leverage your professional network, and get hired.
Epirium
epirium.com- Location: San Diego, CA
- Annual Revenue: $745.0K
- Employees: 3
- Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
Key Information
- Name: Faraday Pharmaceuticals, Inc.
- Category: Pharmaceuticals
- Industry: Pharmaceutical Company
- SIC: 283; 28
- NAICS: 541; 5417
See similar companies
-
By City Seattle Small Pharmaceutical Company in Seattle Mid-size Pharmaceutical Company in Seattle Pharmaceuticals in Seattle Small Pharmaceuticals in Seattle Mid-size Pharmaceuticals in Seattle
-
By State WA Small companies in WA Pharmaceuticals in WA Small Pharmaceuticals in WA Mid-size Pharmaceuticals in WA Small Pharmaceutical Company in WA Mid-size Pharmaceutical Company in WA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Pharmaceutical Company Small Pharmaceutical Company Mid-size Pharmaceutical Company Pharmaceuticals and Pharmaceutical Company
-
Firmographic data G Score of 2 Founded in 2014 SIC: 283 SIC: 28 NAICS: 541 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Faraday Pharmaceuticals, Inc.'s headquarters are located at 1616 Eastlake Ave. E, Ste. 560 560 Seattle, WA 98102.
Faraday Pharmaceuticals, Inc.'s official website is faradaypharma.com
Faraday Pharmaceuticals, Inc.'s annual revenue is $3.5 M.
Faraday Pharmaceuticals, Inc.'s SIC: 283; 28
Faraday Pharmaceuticals, Inc.'s NAICS: 541; 5417.
Faraday Pharmaceuticals, Inc. has 13 employees
Faraday Pharmaceuticals, Inc. is in the industry of Pharmaceuticals.
